CranioNet - An interdisciplinary strategy for craniopharyngioma;CranioNet - Eine interdisziplinäre strategie für das kraniopharyngeom

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 15, 2006, Pages 821-824

  Reschke, K ^a   Busse, S ^a   Mohnike, K ^a   Buchfelder, M ^b   Ranke, M ^c   Fahlbusch, R ^b   Lehnert, H ^d  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

Craniopharyngioma; Hormone evaluation; Hormone replacement therapy; Hypothalamic obesity

Indexed keywords

DESMOPRESSIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE;

CRANIOPHARYNGIOMA; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HYPOPITUITARISM; INTERDISCIPLINARY RESEARCH; REVIEW;

COMBINED MODALITY THERAPY; CONTINUITY OF PATIENT CARE; CRANIOPHARYNGIOMA; HUMANS; HYPOTHALAMIC DISEASES; PITUITARY NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 33646261398     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939854     Document Type: Review

References (19)

1. Bulow B, Attewell R, Hagmar L et al. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 1998; 83: 3897-3904
2. Bunin GR, Surawicz TS, Witman PA et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998; 89: 547-551
3. Buslei R, Nolde M, Hofmann B et al. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol (Berl) 2005; 109: 589-597
4. Chung WY, Pan DH, Shiau CY et al. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 2000; 93: 47-56(Suppl 3
5. Donnet A, Schmitt A, Dufour H, Grisoli F. Neuropsychological follow-up of twenty two adult patients after surgery for craniopharyngioma. Acta Neurochir (Wien) 1999; 141: 1049-1054
6. Fahlbusch R, Honegger J, Paulus W et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999; 90: 237-250
7. Geffner M, Lundberg M, Koltowska-Haggstrom M et al. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 2004; 89: 5435-5440
8. Honegger J, Barocka A, Sadri B, Fahlbusch R. Neuropsychological results of craniopharyngioma surgery in adults: a prospective study. Surg Neurol 1998; 50: 19-28
9. Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 1999; 90: 251-257
10. Kalapurakal JA, Goldman S, Hsieh YC et al. Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer J 2000; 6: 388-393
11. Karavitaki N, Brufani C, Warner JT et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005; 62: 397-409
12. Kendall-Taylor P, Jonsson PJ, Abs R et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 2005; 152: 557-567
13. Lustig RH, Hinds FS, Ringwald-Smith K et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003; 88: 2586-2592
14. Riva D, Pantaleoni C, Devoti M et al. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 1998; 14: 179-184
15. Roth C, Wilken B, Hanefeld F et al. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998; 138: 89-91
16. Scott RM, Hetelekidis S, Barnes PD et al. Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma-a 20-year experience. Pediatr Neurosurg 1994; 21: 75-81(Suppl 1
17. Stahnke N, Grubel G, Lagenstein I, Willig RP. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 1984; 142: 179-185
18. Tomlinson JW, Holden N, Hills RK et al. West Midlands Prospective Hypopituitary Study Group. Association between premature mortality and hypopituitarism. Lancet 2001; 357: 425-431
19. Verhelst J, Kendall-Taylor P, Erfurth EM et al. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J Clin Endocrinol Metab 2005; 90: 4636-4643